Lista de obras -

Absence of Oral Anticoagulation and Subsequent Outcomes Among Outpatients with Atrial Fibrillation

artículo científico publicado en 2016

Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012

artículo científico publicado en 2014

Are statins being underdosed in clinical practice? Data from TACTICS-TIMI 18.

artículo científico publicado en 2005

Association of Atrial Fibrillation Clinical Phenotypes with Treatment Patterns and Outcomes: A Multicenter Registry Study

artículo científico publicado en 2017

Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II

artículo científico publicado en 2018

B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation

scientific article published on 18 September 2018

Cannabinoid-1 receptor blockade in cardiometabolic risk reduction: safety, tolerability, and therapeutic potential.

artículo científico publicado en 2007

Cardiac conduction system disease after transcatheter aortic valve replacement ⬇️

artículo científico publicado el 2 de octubre de 2012

Catheter Ablation of Atrial Fibrillation in U.S. Community Practice--Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

artículo científico publicado en 2015

Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry

Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease

artículo científico publicado en 2014

Comparisons of Guideline-Recommended Therapies in Patients With Documented Coronary Artery Disease Having Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Versus Medical Therapy Only (from the REACH International Registry)

artículo científico publicado en 2007

Cost analysis of periprocedural imaging in patients undergoing catheter ablation for atrial fibrillation.

artículo científico publicado en 2014

Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies ⬇️

artículo científico publicado el 24 de julio de 2013

Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation

scientific article published on 07 January 2020

Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men: Two-Year Results From the ORBIT-AF Registry

artículo científico

Dose-adjusted warfarin: writing the prescription is only the beginning.

artículo científico publicado en 2012

Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)

artículo científico publicado en 2014

Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation

artículo científico publicado en 2013

Effect of Temporary Interruption of Warfarin Due to an Intervention on Downstream Time in Therapeutic Range in Patients With Atrial Fibrillation (from ORBIT AF)

scientific article published on 12 July 2020

Embolic and Other Adverse Outcomes in Symptomatic Versus Asymptomatic Patients With Atrial Fibrillation (from the ORBIT-AF Registry)

scientific article published on 20 August 2018

Factors Associated with Large Improvements in Health-Related Quality of Life in Patients with Atrial Fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)

scientific article published on 16 April 2020

Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).

artículo científico publicado en 2017

Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II).

artículo científico publicado en 2018

Global outcomes of ST-elevation myocardial infarction: comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trial.

artículo científico publicado en 2007

Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation

scientific article published on 08 November 2019

Heart rate is associated with progression of atrial fibrillation, independent of rhythm

artículo científico publicado en 2015

How I use anticoagulation in atrial fibrillation

artículo científico publicado en 2016

How well does physician risk assessment predict stroke and bleeding in atrial fibrillation? Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

artículo científico publicado en 2016

Implementation of Real-Time Assessment of Patient-Reported Outcomes in a Heart Failure Clinic: A Feasibility Study.

artículo científico publicado en 2017

Increased Heart Rate Is Associated With Higher Mortality in Patients With Atrial Fibrillation (AF): Results From the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF)

artículo científico publicado en 2015

International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries

artículo científico publicado en 2017

Is coding for myocardial infarction more accurate now that coding descriptions have been clarified to distinguish ST-elevation myocardial infarction from non-ST elevation myocardial infarction?

artículo científico publicado en 2008

Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry

artículo científico publicado en 2014

Left Atrial Remodeling: Shape Before Size? ⬇️

artículo científico publicado el 9 de abril de 2013

Magnetocardiogram recordings in a nonshielded environment--reproducibility and ischemia detection.

artículo científico publicado en 2005

Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial F

artículo científico publicado en 2017

Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get With The Guidelines database

artículo científico publicado en 2007

Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy

artículo científico publicado en 2006

Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II Registry

artículo científico publicado en 2016

Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation

artículo científico publicado en 2017

Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II: rationale and design of the ORBIT-AF II registry

artículo científico publicado en 2014

Outcomes after nonemergent electrical cardioversion for atrial arrhythmias.

artículo científico publicado en 2015

Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation

artículo científico publicado en 2019

Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice: An Analysis of the ORBIT II Registry

scientific article published on 15 May 2020

Patient Reported Outcomes and Subsequent Management in Atrial Fibrillation Clinical Practice: Results from the Utah mEVAL AF Program

artículo científico publicado en 2020

Quality of Evidence Underlying the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines on the Management of Atrial Fibrillation

artículo científico publicado en 2016

Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry

artículo científico publicado en 2013

Reproducibility of Clinical Late Gadolinium Enhancement Magnetic Resonance Imaging in Detecting Left Atrial Scar after Atrial Fibrillation Ablation

scientific article published on 15 September 2020

Revisiting Rate versus Rhythm Control in Atrial Fibrillation - Timing Matters

scientific article published on 29 August 2020

Rhythm Control Versus Rate Control and Clinical Outcomes in Patients With Atrial Fibrillation

Risk assessment in atrial fibrillation: not all factors are created equal

artículo científico publicado en 2013

Risk of major cardiovascular and neurologic events with obstructive sleep apnea among patients with atrial fibrillation

scientific article published on 07 January 2020

Safety of bivalirudin during percutaneous coronary interventions in patients with abnormal renal function.

artículo científico publicado en 2005

Shared Decision Making in Atrial Fibrillation: Patient-Reported Involvement in Treatment Decisions

artículo científico publicado en 2020

Structure-function relationships of factor Xa inhibitors: implications for the practicing clinician.

artículo científico

Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II

artículo científico publicado en 2019

Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes

artículo científico publicado en 2012

Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry

artículo científico publicado en 2013

Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

artículo científico publicado en 2014

Use of antiarrhythmic drug therapy and clinical outcomes in older patients with concomitant atrial fibrillation and coronary artery disease

artículo científico publicado en 2014

Lista de obras de

Absence of Oral Anticoagulation and Subsequent Outcomes Among Outpatients with Atrial Fibrillation

Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012

Are statins being underdosed in clinical practice? Data from TACTICS-TIMI 18.

Association of Atrial Fibrillation Clinical Phenotypes with Treatment Patterns and Outcomes: A Multicenter Registry Study

Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II

B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation

Cannabinoid-1 receptor blockade in cardiometabolic risk reduction: safety, tolerability, and therapeutic potential.

Cardiac conduction system disease after transcatheter aortic valve replacement ⬇️

Catheter Ablation of Atrial Fibrillation in U.S. Community Practice--Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry

Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease

Comparisons of Guideline-Recommended Therapies in Patients With Documented Coronary Artery Disease Having Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Versus Medical Therapy Only (from the REACH International Registry)

Cost analysis of periprocedural imaging in patients undergoing catheter ablation for atrial fibrillation.

Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies ⬇️

Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation

Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men: Two-Year Results From the ORBIT-AF Registry

Dose-adjusted warfarin: writing the prescription is only the beginning.

Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)

Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation

Effect of Temporary Interruption of Warfarin Due to an Intervention on Downstream Time in Therapeutic Range in Patients With Atrial Fibrillation (from ORBIT AF)

Embolic and Other Adverse Outcomes in Symptomatic Versus Asymptomatic Patients With Atrial Fibrillation (from the ORBIT-AF Registry)

Factors Associated with Large Improvements in Health-Related Quality of Life in Patients with Atrial Fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)

Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).

Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II).

Global outcomes of ST-elevation myocardial infarction: comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trial.

Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation

Heart rate is associated with progression of atrial fibrillation, independent of rhythm

How I use anticoagulation in atrial fibrillation

How well does physician risk assessment predict stroke and bleeding in atrial fibrillation? Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

Implementation of Real-Time Assessment of Patient-Reported Outcomes in a Heart Failure Clinic: A Feasibility Study.

Increased Heart Rate Is Associated With Higher Mortality in Patients With Atrial Fibrillation (AF): Results From the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF)

International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries

Is coding for myocardial infarction more accurate now that coding descriptions have been clarified to distinguish ST-elevation myocardial infarction from non-ST elevation myocardial infarction?

Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry

Left Atrial Remodeling: Shape Before Size? ⬇️

Magnetocardiogram recordings in a nonshielded environment--reproducibility and ischemia detection.

Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial F

Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get With The Guidelines database

Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy

Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II Registry

Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation

Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II: rationale and design of the ORBIT-AF II registry

Outcomes after nonemergent electrical cardioversion for atrial arrhythmias.

Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation

Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice: An Analysis of the ORBIT II Registry

Patient Reported Outcomes and Subsequent Management in Atrial Fibrillation Clinical Practice: Results from the Utah mEVAL AF Program

Quality of Evidence Underlying the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines on the Management of Atrial Fibrillation

Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry

Reproducibility of Clinical Late Gadolinium Enhancement Magnetic Resonance Imaging in Detecting Left Atrial Scar after Atrial Fibrillation Ablation

Revisiting Rate versus Rhythm Control in Atrial Fibrillation - Timing Matters

Rhythm Control Versus Rate Control and Clinical Outcomes in Patients With Atrial Fibrillation

Risk assessment in atrial fibrillation: not all factors are created equal

Risk of major cardiovascular and neurologic events with obstructive sleep apnea among patients with atrial fibrillation

Safety of bivalirudin during percutaneous coronary interventions in patients with abnormal renal function.

Shared Decision Making in Atrial Fibrillation: Patient-Reported Involvement in Treatment Decisions

Structure-function relationships of factor Xa inhibitors: implications for the practicing clinician.

Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II

Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes

Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry

Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

Use of antiarrhythmic drug therapy and clinical outcomes in older patients with concomitant atrial fibrillation and coronary artery disease